Methotrexate PF
1000 mg / 40 mL PF
in NaCl
NDC: 73177-0168-45
BUD: 180


STAQ Pharma, a hospital-owned 503B outsourcing supplier committed to alleviating drug shortages, announced the launch of their oncology portfolio at a ceremony held at their Columbus, OH, facility on Friday, July 26.


0.2% in 0.9% Sodium Chloride PF
NDC: 73177-0109-27
BUD: XXX












We work closely with hospitals to quickly develop and produce the most highly sought after medications while maintaining strict adherence to FDA regulations.

With state-of-the-art machinery and two cGMP-compliant facilities, STAQ is constantly developing new and innovative compounded products.

STAQ Pharma Honored with the Prestigious 2024 Heartbeat of Healthcare Supplier Award Denver, CO – March 6, 2024 – STAQ Pharma, a leading 503B Outsourcing Facility, is pleased to announce its selection of the prestigious 2024 Heartbeat of Healthcare Supplier Award. This accolade was presented to STAQ Pharma’s leadership team during the Federation of American …

STAQ Pharma is working with the nonprofit scientific research organization IAVI to provide support services for the production of an innovative intranasal spray targeting COVID-19. This multi-partner project aims to produce a miniprotein anti-viral blocker delivered via an intranasal device. STAQ Pharma's expertise in aseptic processing and experience with similar devices make them a key player in this project.

On October 5th, several members of the Columbus community, including STAQ employees and Board of Directors celebrated the grand opening of STAQ Pharma’s newest location in Columbus, Ohio. Read more from RX Insider.

An ongoing shortage of albuterol, a critical medicine for treating breathing problems, has intensified following the shutdown of a major supplier to U.S. hospitals. STAQ Pharma, a hospital-owned 503B outsourcing supplier, has been instrumental in addressing this crisis by producing compounded pediatric albuterol medications to meet the needs of children’s hospitals. As supply chain issues …

With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.

Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2022. In partnership with Children’s Hospital Colorado (CHC), STAQ has been able to supply and maintain continuous albuterol for children’s hospitals. STAQ is committed to getting pediatric hospitals through this respiratory season and helping to …

Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.
